WallStreetZenWallStreetZen

NASDAQ: AVBP
Arrivent Biopharma Inc Stock Ownership - Who owns Arrivent Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arrivent Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Hillhouse Investment Management Ltd10% Owner2025-12-10555,555$23.37
$12.98MSell
Robin LachapelleChief Operating Officer2025-07-112,050$2.28
$4.67kBuy
Robin LachapelleChief Operating Officer2025-07-112,600$2.28
$5.93kBuy
Robin LachapelleChief Operating Officer2025-07-116,503$2.28
$14.83kBuy

1 of 1

AVBP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVBP insiders and whales buy or sell their stock.

AVBP Shareholders

What type of owners hold Arrivent Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Infinitum Asset Management LLC9.33%4,123,923$121.66MInstitution
Suvretta Capital Management LLC9.29%4,106,035$121.13MInstitution
Hhlr Advisors Ltd8.89%3,929,117$115.91MInstitution
Hillhouse Investment Management Ltd8.89%3,929,117$115.91MInsider
Fmr LLC8.38%3,703,572$109.26MInstitution
Orbimed Advisors LLC6.85%3,027,328$89.31MInstitution
Blackrock Inc5.37%2,372,838$70.00MInstitution
Octagon Capital Advisors LP4.46%1,971,054$58.15MInstitution
Novo Holdings A4.39%1,942,142$57.29MInstitution
Vanguard Group Inc4.23%1,869,266$55.14MInstitution

1 of 3

AVBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVBP80.12%19.88%Net Selling
WVE78.30%21.70%Net BuyingNet Buying
BHVN78.70%15.72%Net Buying
KALV62.24%37.76%Net SellingNet Selling
CRVS55.52%38.89%Net Buying
View Top Biotech Stocks

Arrivent Biopharma Stock Ownership FAQ

Who owns Arrivent Biopharma?

Arrivent Biopharma (NASDAQ: AVBP) is owned by 86.11% institutional shareholders, 21.37% Arrivent Biopharma insiders, and 0.00% retail investors. Hillhouse Investment Management Ltd is the largest individual Arrivent Biopharma shareholder, owning 3.93M shares representing 8.44% of the company. Hillhouse Investment Management Ltd's Arrivent Biopharma shares are currently valued at $114.02M.

If you're new to stock investing, here's how to buy Arrivent Biopharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.